Ebola vaccine trial begins in DR Congo's Ituri
A clinical trial called TUMAini has started in Bunia, in DR Congo's Ituri province. It will test candidate vaccines against the Bundibugyo strain of Ebola. One is Ervebo, already approved for the more common Zaire strain.
Why it matters
There is no approved vaccine for the Bundibugyo strain driving this outbreak.
Background
Ebola is a deadly virus spread through bodily fluids. Vaccines have helped control past outbreaks of the Zaire strain.
The story so far
- Ebola vaccine trial begins in DR Congo's Ituri
- Last Ebola patients leave Ituri center
- Congo center discharges last Ebola patients
Sources
- Africanews ↗Oct 24, 4:38 AM ET
- The Hindu ↗Oct 24, 2:01 AM ET
This summary was written automatically from the reporting linked above; follow the sources for the full story. How One Turn works.